Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients

Figure 2

HCV viral loads in patients with and without genetic DR4 risk variants. This Figure shows HCV viral loads (Means ± SEM) in patients who carry the DR4 626CG or 626CC risk variant (left columns), the DR4 683AA risk variant (middle columns) and both DR4 risk variants simultaneously (right columns). Dark columns refer to patients with the studied risk factor, grey columns to those without the risk factor, respectively. Differences were compared by ANOVA.

Back to article page